174 related articles for article (PubMed ID: 363387)
1. The skin as a drug-metabolizing organ.
Pannatier A; Jenner P; Testa B; Etter JC
Drug Metab Rev; 1978; 8(2):319-43. PubMed ID: 363387
[No Abstract] [Full Text] [Related]
2. Biotransformation of drugs in human skin.
Svensson CK
Drug Metab Dispos; 2009 Feb; 37(2):247-53. PubMed ID: 19005027
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of xenobiotic-metabolizing enzymes in liver and intestine of various animal species.
Chhabra RS; Pohl RJ; Fouts JR
Drug Metab Dispos; 1974; 2(5):443-7. PubMed ID: 4156307
[No Abstract] [Full Text] [Related]
4. Drug metabolism: prospects for the future.
Leibman KC
Drug Metab Rev; 1979; 10(2):299-309. PubMed ID: 121804
[No Abstract] [Full Text] [Related]
5. [The effect of foreign-substance-metabolizing enzymes on skin diseases].
Goerz G; Merk H
Hautarzt; 1992 Feb; 43(2):65-72. PubMed ID: 1548130
[TBL] [Abstract][Full Text] [Related]
6. Monooxygenase reactions, glucuronic acid and sulphate conjugation in isolated hepatocytes.
Bridges JW
Toxicology; 1980; 18(3):195-204. PubMed ID: 7222051
[No Abstract] [Full Text] [Related]
7. Genetic factors in hepatic drug oxidation.
Kalow W; Inaba T
Prog Liver Dis; 1976; 5():246-58. PubMed ID: 775542
[No Abstract] [Full Text] [Related]
8. Genetic polymorphisms in drug-metabolizing enzymes and drug targets.
Hiratsuka M; Mizugaki M
Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011
[No Abstract] [Full Text] [Related]
9. Stability of drug-metabolizing activities in lyophilized liver and lung microsomal preparations.
Patel JM; Ortiz E; Shiverick KT; Leibman K
Drug Metab Dispos; 1983; 11(6):620-1. PubMed ID: 6140152
[No Abstract] [Full Text] [Related]
10. Differences in inducibility of cutaneous and hepatic drug metabolizing enzymes and cytochrome P-450 by polychlorinated biphenyls and 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT).
Bickers DR; Kappas A; Alvares AP
J Pharmacol Exp Ther; 1974 Feb; 188(2):300-9. PubMed ID: 4204348
[No Abstract] [Full Text] [Related]
11. Factors regulating drug metabolism in intact hepatocytes.
Thurman RG; Kauffman FC
Pharmacol Rev; 1979 Dec; 31(4):229-51. PubMed ID: 399807
[No Abstract] [Full Text] [Related]
12. Foreign compound metabolism in the liver.
Bentley P; Oesch F
Prog Liver Dis; 1982; 7():157-78. PubMed ID: 7051143
[No Abstract] [Full Text] [Related]
13. [The role of drug metabolizing enzymes in the effect and side-effect of the drugs].
Vereczkey L; Jemnitz K; Monostory K; Veres Z; Kóbori L
Orv Hetil; 2005 May; 146(19):947-52. PubMed ID: 15969306
[TBL] [Abstract][Full Text] [Related]
14. A reevaluation of the role of cytochrome P-450 as the terminal oxidase in hepatic microsomal mixed function oxidase catalyzed reactions.
Cooper DY; Schleyer H; Levin SS; Eisenhardt RH; Novack BG; Rosenthal O
Drug Metab Rev; 1979; 10(2):153-85. PubMed ID: 399457
[No Abstract] [Full Text] [Related]
15. Drug metabolism by placenta.
Juchau MR; Pedersen MG; Fantel AG; Shepard TH
Clin Pharmacol Ther; 1973; 14(4):673-9. PubMed ID: 4146366
[No Abstract] [Full Text] [Related]
16. Drug biotransformation in the placenta.
Juchau MR
Pharmacol Ther; 1980; 8(3):501-24. PubMed ID: 6992160
[No Abstract] [Full Text] [Related]
17. Studies on the molecular function of cytochrome P-450 during drug metabolism.
Estabrook RW; Matsubara T; Mason JI; Werringloer J; Baron J
Drug Metab Dispos; 1973; 1(1):98-110. PubMed ID: 4149428
[No Abstract] [Full Text] [Related]
18. [Liver and metabolism of drugs].
Darnis F
Cah Med; 1974 Oct; 15(10):637-43. PubMed ID: 4455367
[No Abstract] [Full Text] [Related]
19. Commentary: drug metabolism and pharmacogenetics.
La Du BN
Drug Metab Dispos; 1983; 11(4):283-5. PubMed ID: 6137331
[No Abstract] [Full Text] [Related]
20. Molybdenum hydroxylases as drug-metabolizing enzymes.
Beedham C
Drug Metab Rev; 1985; 16(1-2):119-56. PubMed ID: 3905316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
